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التقلبات يف مستويات األجسام املضادة للكارديوليبني وبيتا2- جليكوبروتني عند 
النساء احلوامل
 حممد البلو�سي، �سدقي ح�سن، اإليا�س �سعيد، جمعة البو�سعيدي، منى الديهاين، حممد عثمان، طالل �سالم، حممد اإدري�س، موزة الكلبانية،
نيكوال�س وودهاو�س، على اجلابري
abstract: Objectives: Antiphospholipid antibodies fluctuate during a healthy normal pregnancy. This study aimed 
to investigate the levels of both immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies for cardiolipin 
and β2-glycoprotein (β2GP) among healthy pregnant women. Methods: This study was conducted between May 
2010 and December 2012. A total of 75 healthy Omani pregnant women with no history of autoimmune disease 
were investigated during their pregnancy and 90 days after delivery at the Armed Forces Hospital in Muscat, Oman. 
A control group of 75 healthy Omani non-pregnant women were also investigated as a comparison. Levels of IgM 
and IgG antibodies for both anti-cardiolipin antibodies (ACAs) and β2GP were measured using a standard enzyme-
linked immunosorbent assay. Results: The ACA IgM levels were significantly higher in the control group compared 
to the pregnant women (P <0.001). No significant differences were observed in the ACA IgM levels between the 
control group and the pregnant women after delivery. In contrast, ACA IgG levels were significantly higher during 
pregnancy and after delivery compared with those of the healthy control group (P = 0.007 and 0.002, respectively). 
The levels of β2GP IgG were significantly higher during pregnancy than after delivery and in the control group 
(P = 0.001 and <0.001, respectively). Conclusion: In this study, ACA IgG levels increased during healthy pregnancies 
and after normal deliveries whereas β2GP IgG levels increased transiently during the pregnancies. Both phenomena 
were found to be significantly associated with a transient decline in the levels of IgM specific for these antigens. 
Therefore, the levels of these antibodies may be regulated during a healthy pregnancy.
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للتحقق من م�ستويات  الدرا�سة  الطبيعي. هدفت هذه  اأثناء فرتة احلمل  للفو�سفوليبيد يتقلب  االأج�سام امل�سادة  الهدف: م�ستوى  امللخ�ص: 
الدرا�سة االأج�سام امل�سادة IgM واالأج�سام امل�سادة IgG للكارديولبني )ACA( و دهون البيتا-2 جليكوبروتني )β2GP( بني الن�ساء العمانيات  و�سملت    .2012 االأول/دي�سمرب،  وكانون   ،2010 اأيار/مايو  بني  الدرا�سة  هذه  اأجريت  الطريقة:  �سليم.  �سحي  بحمل  احلوامل 
جمموعة أوىل مكونة من 75 إمراأة عمانية حامل بحمل طبيعي �سحي غري م�سابات باأمرا�س املناعة الذاتية ومت حتليل العينات خالل 
فرتة احلمل و 90 يوما بعد الوالدة. كما �سملت هذه الدرا�سة 75 من الن�ساء غري احلوامل كمجموعة مراقبة على �سبيل املقارنة. مت قيا�س 
كانت  النتائج:   .)ELISA(االإليزا طريقة  2-جليكوبروتنيبا�ستخدام  بيتا  و  للكارديولبني  امل�سادة  االأج�سام  امل�سادة  االأج�سام  م�ستويات 
الن�ساء احلوامل  اأعلى بكثري يف جمموعة املراقبة باملقارنة مع م�ستويات IgM يف  للكارديولبني   IgM االأج�سام امل�سادة  م�ستويات 
الوالدة. ويف  بعد  الن�ساء احلوامل  املراقبة وجمموعة  بني جمموعة   IgM P(. مل توجد فروق مهمة لوحظت يف م�ستويات   >0.001(
املقابل كانت م�ستويات IgG للكارديولبني اأعلى بكثري اأثناء فرتة احلمل وبعد الوالدة باملقارنة مع جمموعة املقارنة )P = 0.007 و 
P = 0.002، على التوايل(.اأما االج�سام امل�سادة IgG لدهون البيتا-2 جليكوبروتني فكانت امل�ستويات اأعلى بكثري خالل احلمل من 
بعد الوالدة، ويف جمموعة املقارنة أي�سا )P = 0.001 و0.01<، على التوايل(. الخالصة: يف هذه الدرا�سة، وجدت زيادة يف م�ستويات 
IgG للكارديولبني اأثناء احلمل الطبيعي وبعد الوالدات الطبيعية بينما زادت م�ستويات IgG لدهون البيتا-2 جليكوبروتني زيادة عابرة 
اأثناء فرتة احلمل. ومت العثور على كل هذه الظواهر مرتبطة اإىل حد كبري مع انخفا�س عابر يف م�ستويات حمددة لهذه امل�سادات IgM مما 
قد ينظم م�ستويات هذه االأج�سام امل�سادة اأثناء فرتة احلمل الطبيعي.
مفتاح الكلمات: االأج�سام امل�سادة الكارديولبني؛ بيتا 2-جليكوبروتني؛ حمل؛ ن�ساء؛ عمان.
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Antiphospholipid antibodies (APLAs) have been detected in up to 5% of healthy Omani individuals.1 In a prospective study 
by Lynch et al., these autoantibodies were found to 
include the antibodies countering cardiolipin and 
β2-glycoprotein (β2GP), which are directed against 
phospholipid-binding proteins.2 Furthermore, a 
study by Harris et al. indicated that anti-cardiolipin 
antibodies (ACAs) were associated with recurrent 
pregnancy loss.3 These studies have also documented 
the presence of ACAs in pregnant women as a valuable 
indicator for recurrent abortions and fetal wastage, 
both in patients with autoimmune diseases and in 
those with no apparent autoimmune diseases.1–3 Other 
studies, however, have not confirmed the significance 
of the presence of ACAs during pregnancy.4–7 The 
changes in APLA levels during pregnancy remain 
obscure.8–16 In an early study based on recurrent 
miscarriages, it was discovered that approximately 
20% of the studied women had persistent APLAs 
before conception.17 In some cases, a rise in the ACA 
titre has been noted during early pregnancy.11–16
Pregnancy is known to be associated with a T 
helper-2 (Th2) environment which is thought to enable 
the maintenance of a normal healthy pregnancy. 
However, the real mechanisms of and reasons 
for the shift towards a Th2 profile have yet to be 
elucidated.17,18 This study aimed to detect the levels of 
both immunoglobulin M (IgM) and immunoglobulin 
G (IgG) antibodies specific for both cardiolipin and 
β2GP during and after a healthy normal pregnancy. 
Methods
This study was conducted between May 2010 and 
December 2012 and included a total of 150 Omani 
women. Of this group, 75 were healthy pregnant 
women who attended the antenatal care outpatient 
clinic of the Department of Obstetrics & Gynaecology 
at the Armed Forces Hospital in Muscat, Oman. 
Healthy non-pregnant women (n = 75) were recruited 
from the Sultan Qaboos University Hospital blood 
bank and acted as the control group; they were 
investigated in parallel with the pregnant women. In 
both groups, women with the following conditions 
were excluded from the study: diagnosed connective 
tissue disease or other autoimmune diseases, or a 
previous history of thromboembolisms, recurrent 
abortions or treatments affecting the immune 
response, such as corticosteroids, immunosuppressive 
drugs or immunomodulators. The pregnant women 
were followed up for these conditions throughout 
their pregnancy and after delivery. 
Blood samples were collected from the control 
group (never pregnant women) and from the pregnant 
women, both during their first trimester and 90 
days after delivery. The sera were separated after 
centrifugation at 4,000 rpm in a cooling centrifuge. 
All sera were tested for ACA (using IgM and IgG) 
and β2GP levels using a standard enzyme-linked 
immunosorbent assay (EUROIMMUN Corp., 
Lübeck, Germany), following the manufacturer’s 
recommendations. The results were expressed in 
relative units per millilitre (RU/mL). In order to fulfil 
the Sapporo criteria for antiphospholipid syndrome, 
autoantibodies were tested twice, with an interval of 
six weeks between the tests, to distinguish the levels of 
the antibody response. 
Collected data were then analysed using various 
statistical tests. A Wilcoxon signed-rank test was 
performed to assess the significance of the changes in 
antibody levels during pregnancy and after delivery. 
Furthermore, to assess the significance of such 
changes, the levels of autoantibodies obtained from 
the pregnant women during pregnancy and after 
delivery were compared with the control group of non-
pregnant women using the Mann-Whitney U test. The 
significance of the correlations was calculated using 
Spearman’s rank correlation coefficient. Differences in 
antibody levels were considered significant at P <0.05.
Ethical approval for this study was obtained 
from the Medical Research & Ethics Committee of 
the College of Medicine & Health Sciences at Sultan 
Qaboos University in Muscat, Oman (MREC #654). 
All of the women involved in the study gave signed 
informed consent before participation.
Advances in Knowledge
- Similarities in the fluctuation patterns of cardiolipin and β2-glycoprotein (β2GP) autoantibodies were noted among a group of healthy 
pregnant women.
- Levels of both anti-cardiolipin antibodies (ACAs) and β2GP immunoglobulin G (IgG) were found to increase significantly during healthy 
normal pregnancies. However, the increase of these levels does not pose a danger to either the woman or the fetus during a healthy 
normal pregnancy unless the levels reach a certain threshold.
Application to Patient Care
- While increased levels of both ACA and β2GP IgG antibodies may be a normal physiological phenomenon during pregnancy, the factors 
that lead autoantibodies to become pathogenic are currently obscure. In view of this, the authors of this study support the current 
autoantibody measurement practices during pregnancy.
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Results
A total of 150 healthy Omani women were investigated, 
with 75 pregnant women and 75 controls. The mean 
ages of the pregnant women and the control group 
were 24 and 27 years, respectively. All investigated 
pregnant women had uncomplicated pregnancies and 
normal pregnancy outcomes. Approximately 80% of 
the pregnant women had been pregnant before their 
current pregnancies.
Increased levels of IgG were associated with 
a transient decrease of ACA IgM levels during 
pregnancy. The average IgM level after delivery (3.5 
RU/mL) was significantly higher than that during 
pregnancy (2.6 RU/mL; P ≤0.01) [Figure 1A]. A similar 
pattern was found with the serum ACA IgG, with an 
average of 3.2 RU/mL after delivery in comparison to 
an average of 2.4 RU/mL during pregnancy (P ≤0.01) 
[Figure 1B].
The average ACA IgM level was significantly 
higher in the control group (3.98 RU/mL) than in the 
pregnant women during their pregnancies (P <0.001) 
[Figure 2A]. However, no significant differences were 
seen in the ACA IgM levels between the control group 
and the pregnant women after delivery. In contrast, 
ACA IgG levels were significantly higher during 
and after pregnancy when compared to those of the 
healthy control group, with an average of 1.8 RU/mL 
(P = 0.007 and 0.002, respectively) [Figure 2B].
Among the pregnant women, a transient 
increase in the levels of β2GP IgG was associated 
with a transient decrease of ACA IgM levels during 
pregnancy. The average IgM level after delivery (8.4 
RU/mL) was significantly higher than the average 
during pregnancy (2.2 RU/mL; P ≤0.01) [Figure 3A]. In 
addition, a decrease was observed in the average level 
of β2GP IgG after delivery (1.4 RU/mL) in contrast 
to the average level during pregnancy (2.0 RU/mL; 
P ≤0.01) [Figure 3B].
The average level of β2GP IgM was significantly 
 
Figure 1 A & B: Increased levels of anti-cardiolipin antibody (A) immunoglobulin M and (B) immunoglobulin G were 
observed among the pregnant group of women after delivery in comparison to those recorded during their pregnancies 
(n = 75).
ACA = anti-cardiolipin antibody; IgM = immunoglobulin M; IgG = immunoglobulin G; RU/mL = relative units per millilitre.
 
Figure 2 A & B: In comparison to the control group (n = 75), there were (A) decreased levels of anti-cardiolipin antibody 
(ACA) immunoglobulin M and (B) increased levels of ACA immunoglobulin G among the pregnant women (n = 75), 
both during pregnancy and after delivery. 
ACA = anti-cardiolipin antibody; IgM = immunoglobulin M; IgG = immunoglobulin G; RU/mL = relative units per millilitre. 
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lower during pregnancy in comparison to after 
delivery and in the control group (8.9 RU/mL; 
P <0.01 and <0.01, respectively) [Figure 4A]. However, 
no significant differences were observed in the ACA 
IgM levels during pregnancy in comparison to those 
recorded after delivery or among the control group.  
The levels of β2GP IgG were found to be 
significantly higher during pregnancy in contrast to 
the levels recorded after delivery and in the control 
group (1.2 RU/mL; P = 0.001 and <0.001, respectively) 
[Figure 4B].
The levels of both ACA IgG and β2GP IgG were 
significantly higher in the pregnant women than in the 
healthy non-pregnant control group, by 1.3 and 1.6 
times, respectively. Moreover, as the pregnant women’s 
β2GP IgG decreased after delivery to levels similar to 
those found in non-pregnant women, the ACA IgG 
levels were still 1.8 times higher after delivery when 
compared with the control group. Interestingly, the 
increase of IgG levels during pregnancy was associated 
with a transient 40% and 80% decrease in IgM levels 
against both ACA and β2GP, respectively [Figures 5A 
& B].
There were similarities in the fluctuation pattern 
of ACA and β2GP autoantibodies in healthy pregnant 
women. While the results obtained showed that 
the levels of both ACA IgG and β2GP IgG were 
significantly correlated during pregnancy (ρ = 0.3; 
P = 0.008) [Figure 6A], no correlation was detected 
between the level of these autoantibodies after delivery 
and in the control group. Furthermore, the IgM levels 
of both ACA and β2GP were significantly correlated 
during pregnancy (ρ = 0.4; P <0.001) [Figure 6B], after 
delivery (ρ = 0.5; P <0.001) [Figure 6C] and in the 
control group (ρ = 0.4; P <0.001) [Figure 6D]. The ratio 
of IgG ACAs to IgM ACAs was significantly correlated 
with the IgG to IgM ratio for β2GP during pregnancy 
(ρ = 0.5; P <0.001) [Figure 6E] and after delivery (ρ = 
0.34; P = 0.004) [Figure 6F].
 
Figure 3 A & B: When compared to the levels observed during pregnancy, there were (A) increased levels of anti-β2-
glycoprotein (β2GP) immunoglobulin M and (B) decreased levels of anti-β2GP immunoglobulin G among the women 
after delivery (n = 75). 
β2GP = β2-glycoprotein; IgM = immunoglobulin M; IgG = immunoglobulin G; RU/mL = relative units per millilitre. 
 
Figure 4 A & B: Pregnancy induces (A) a transient decrease of anti-anti-β2-glycoprotein (β2GP) immunoglobulin M levels 
associated with (B) a transient increase in anti-β2GP immunoglobulin G levels (N = 150; n = 75 for each group). 
β2GP = β2-glycoprotein; IgM = immunoglobulin M; IgG = immunoglobulin G; RU/mL = relative units per millilitre. 
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Figure 5 A & B: Increased anti-cardiolipin antibody (ACA) and β2-glycoprotein (β2GP) immunoglobulin G (IgG) levels 
were observed during pregnancy (n = 75) in comparison to the never pregnant control group (n = 75). This was associated 
with a transient decrease in immunoglobulin M (IgM) levels directed against these self-antigens. A: Fold increase of ACA 
IgM and IgG levels. B: Fold increase of anti-β2GP IgM and IgG levels. The values here are calculated based on the mean 
values of the previous figures. 
ACA = anti-cardiolipin antibody; β2GP = β2-glycoprotein; IgG = immunoglobulin G; IgM = immunoglobulin M; RU/mL = relative units per 
millilitre; Np = never pregnant. 
 
Figure 6 A−F: A correlation was found between anti-cardiolipin antibody (ACA) and anti-β2-glycoprotein 
(anti-β2GP) autoantibodies and (A) immunoglobulin G (IgG) levels. Additionally, correlations were found 
between ACA and anti-β2GP autoantibodies and immunoglobulin M (IgM) levels (B) during pregnancy, 
(C) after delivery and in (D) non-pregnant women, respectively. Correlations were also found between 
the ratios of IgG to IgM for ACA and anti-β2GP both (E) during pregnancy and (F) after a normal delivery 
(N = 150; n = 75 for each group).
ACA = anti-cardiolipin antibody; β2GP = β2-glycoprotein; IgG = immunoglobulin G; IgM = immunoglobulin M; RU/mL = relative units per 
millilitre. 
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Discussion
The results of this study show that levels of ACA and 
β2GP IgG were significantly higher during pregnancy 
when compared with a non-pregnant control group. 
Furthermore, although the β2GP IgG levels of the 
pregnant women decreased after delivery, their ACA 
IgG levels remained high. The increase of these 
IgG levels during pregnancy was associated with a 
transient decrease in IgM levels. Although these 
autoantibodies did not reach pathogenic levels, 
such results suggest that pregnancy promotes the 
production of these autoantibodies. The presence of 
autoantibodies at non-pathogenic levels is thought to 
be important in maintaining homeostasis as they may 
help the body eliminate the self-structures resulting 
from cellular or tissue damage.19 Levels of these 
autoantibodies may therefore assist in the avoidance of 
the accumulation of cellular debris that results from cell 
death, including the apoptotic process. The potential 
role of these autoantibodies in tumour surveillance, 
however, needs to be further investigated.20 
The changes in IgG and IgM levels observed in this 
study could be due to the Th2 cytokine environment 
that is associated with and thought to enable the 
maintenance of a normal healthy pregnancy.14 
However, the exact mechanisms of and reasons for the 
shift towards a Th2 cytokine profile remain elusive, 
although hormonal changes have been suggested as 
a possible cause.21 The inhibition of the T-helper 1 
(Th1) immune response might be important for the 
survival of the fetus. In fact, while the Th1 response 
is a pro-inflammatory response, the Th2 response has 
a tolerogenic effect. It is well established that isotype 
switching from IgM to certain subclasses of IgG (such 
as IgG1, the predominant IgG subclass) is a Th2-
dependent phenomenon.15 Therefore, the Th2 profile 
during a normal healthy pregnancy might be related 
to the increase of self-recognising IgM and IgG levels. 
Of note, no significant differences were found in the 
antibody levels of IgM and IgG specific for ACAs and 
β2GPs between women who had been pregnant before 
and those who were pregnant for the first time. 
Interestingly, the results obtained in this 
study showed that ACA and β2GP IgG levels were 
significantly correlated with each other only during 
pregnancy. This may also be explained by the Th2 
cytokine environment believed to occur during a 
normal healthy pregnancy.16 This theory is supported 
by the present study’s results, which found significant 
correlations between the ratio of IgG to IgM levels for 
both ACAs and β2GPs. Moreover, another explanation 
for such a correlation is that the fifth domain of β2GP 
contains a phospholipid-binding site (Cys281-Cys288) 
and a region recognised by ACAs.17,18 Consequently, 
when the β2GP antigen is available, it might elicit 
autoantibodies that recognise both ACAs and β2GPs 
at the same time. Furthermore, and unlike IgG levels, 
ACA and β2GP IgM levels were significantly correlated 
in the pregnant group during pregnancy and after 
delivery, as well as in the control group. The presence of 
such a correlation (with reference to the levels of IgM 
but not IgG in non-pregnant women) can be explained 
by the induction of this isotype at a basal level, for 
reasons that remain elusive. The observed correlation 
of ACA and β2GP IgM levels during pregnancy and 
after delivery might be due to the similarities that are 
found in the patterns of fluctuation for IgM levels, 
which is not the case for IgG levels after delivery. 
The results of this study clearly showed the 
correlation between ACA and β2GP autoantibodies, 
corroborating previous findings that illustrated 
similar correlations among pregnant women 
who experienced spontaneous abortions or pre-
eclampsia.22,23 It is worth noting that the correlation 
between ACA and β2GP IgG levels was also found in 
some autoimmune diseases, such as systemic lupus 
erythematosus and antiphospholipid syndrome, as 
well as in some infectious diseases, including human 
immunodeficiency virus infection, leprosy and 
malaria.24–27 The increase in ACA and β2GP IgG levels 
occurs even during a healthy pregnancy; however, this 
increase does not present a threat to the maintenance 
of the pregnancy unless these autoantibodies reach a 
certain threshold.28 The mechanisms that lead to such 
a pathogenic effect have yet to be confirmed. 
In general, autoantibodies have a negative effect 
on the maintenance of a healthy pregnancy. However, 
the relationship between ACA levels and recurrent 
pregnancy loss remains controversial.1–5 For example, 
a decrease in the concentration of APLAs has been 
associated with a successful pregnancy outcome in 
some studies, whereas others have shown that the 
relationship between ACA levels and pregnancy loss 
is not significant at all.29–32 Consequently, the present 
study’s results on the fluctuation of ACA levels during 
a normal pregnancy may explain the discrepancies 
reported by different research groups, as the presence 
of these autoantibodies did not have a negative 
influence on the pregnancy, most likely because they 
were at non-pathogenic levels. Finally, it is interesting 
that the ACA IgG levels observed in this study 
increased even after delivery, while β2GP IgG levels 
declined to normal levels.
The results of the current study reflect the 
increase of specific autoantibodies during pregnancy. 
However, this increase might be general to different 
autoantibodies, as it is very likely a result of the 
Fluctuation in the Levels of Immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and β
2
-Glycoprotein among Healthy 
Pregnant Women
e484 | SQU Medical Journal, November 2014, Volume 14, Issue 4
particular immunological environment associated 
with pregnancy. Further studies should be performed 
on a larger sample size and should investigate a greater 
number of autoantibodies, such as anti-thyroid 
peroxidase antibodies, anti-nuclear antibodies and 
anti-double stranded deoxyribonucleic acid. 
Conclusion
Among these samples of healthy pregnant women, 
ACA and β2GP autoantibodies were found to 
increase to levels that do not present a threat to the 
maintenance of a healthy normal pregnancy. This 
phenomenon could be due to an increase in isotype 
switching, as seen by the decrease of IgM levels. The 
factors that lead autoantibodies to become pathogenic 
are currently unknown.
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